Evogene Announces Pricing of US$8,500,000 Registered Direct Offering
- Monday, July 17, 2023, 7:15
- PR Newswire
- Add a comment
REHOVOT, Israel, July 17, 2023 /PRNewswire/ — Evogene Ltd. (“Evogene”) (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development utilizing cutting-edge computational biology technologies across…
About the Author
admin has written 21643 stories on this site.